Clinical Trial Update: Study to Evaluate the Safety and Analgesic Activity of ATx08-001 in Subjects With Postherpetic Neuralgia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and analgesic activity of ATx08-001 in subjects with postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• ATx08-001

Snippet

Sponsor: Aestus Therapeutics | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED